Company Overview of Biosortia Pharmaceuticals, Inc.
Biosortia Pharmaceuticals, Inc. develops and commercializes bioactive compounds from aquatic microorganisms for drug discovery. The company’s technology enables to conduct exploratory stage harvest operations for evaluation of aquatic biomass consortia. Its technology reduces costs for obtaining algal biomass for high-value products. The company develops technologies and systems for effective algal biomass harvesting. The company was formerly known as Algaeventure Systems, Inc. The company was founded in 2008 and is based in San Diego, California. Biosortia Pharmaceuticals, Inc. is a former subsidiary of Univenture, Inc.
3210 Merryfield Row
San Diego, CA 92121
Founded in 2008
Key Executives for Biosortia Pharmaceuticals, Inc.
Biosortia Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
December 15, 2015
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Biosortia Pharmaceuticals, Inc., please visit www.biosortia.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.